Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UQCRB antisense RNA 1 (UQCRB-AS1) is a long non-coding RNA (lncRNA), transcriptionally oriented in the antisense direction to the UQCRB gene locus. As a non-coding transcript, it does not encode a protein but may have regulatory functions with respect to the expression of the UQCRB gene, which encodes a subunit of mitochondrial complex III involved in electron transport, angiogenesis, and hypoxia signaling. However, the specific properties, cellular functions, and clinical relevance of UQCRB-AS1 remain uncharacterized in published literature and are not curated in major gene or protein databases. There is no evidence to suggest it is a direct disease gene, therapeutic target, or biomarker.
Not characterized. No mechanisms of action for drugs targeting this molecule are described.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UQCRB antisense RNA 1 (UQCRB-AS1).